title: Nonhomologous end joining and V(D)J recombination require an additional factor.
abstract: DNA nonhomologous end-joining (NHEJ) is the major pathway for repairing DNA double-strand breaks in mammalian cells. It also functions to carry out rearrangements at the specialized breaks introduced during V(D)J recombination. Here, we describe a patient with T(-)B(-) severe combined immunodeficiency, whose cells have defects closely resembling those of NHEJ-defective rodent cells. Cells derived from this patient show dramatic radiosensitivity, decreased double-strand break rejoining, and reduced fidelity in signal and coding joint formation during V(D)J recombination. Detailed examination indicates that the patient is defective neither in the known factors involved in NHEJ in mammals (Ku70, Ku80, DNA-dependent protein kinase catalytic subunit, Xrcc4, DNA ligase IV, or Artemis) nor in the Mre11/Rad50/Nbs1 complex, whose homologue in Saccharomyces cerevisiae functions in NHEJ. These results provide strong evidence that additional activities are crucial for NHEJ and V(D)J recombination in mammals.
authors.affiliation: Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Dai
authors.forename: B
authors.initials: B
authors.lastname: Kysela
authors.forename: L A
authors.initials: LA
authors.lastname: Hanakahi
authors.forename: K
authors.initials: K
authors.lastname: Manolis
authors.forename: E
authors.initials: E
authors.lastname: Riballo
authors.forename: M
authors.initials: M
authors.lastname: Stumm
authors.forename: T O
authors.initials: TO
authors.lastname: Harville
authors.forename: S C
authors.initials: SC
authors.lastname: West
authors.forename: M A
authors.initials: MA
authors.lastname: Oettinger
authors.forename: P A
authors.initials: PA
authors.lastname: Jeggo
mesh_terms: D000818:Animals; D020134:Catalytic Domain; D002478:Cells, Cultured; D004249:DNA Damage; D000072481:DNA Ligase ATP; D011088:DNA Ligases / Q000378:metabolism; D004254:DNA Nucleotidyltransferases / Q000737:chemistry* / Q000378:metabolism; D004260:DNA Repair; D018076:DNA, Complementary / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D004307:Dose-Response Relationship, Radiation; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D015151:Immunoblotting; D007153:Immunologic Deficiency Syndromes / Q000235:genetics* / Q000378:metabolism*; D010455:Peptides / Q000737:chemistry; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors; D014407:Tumor Cells, Cultured; D045567:VDJ Recombinases
chemical_list: D018076:DNA, Complementary; D004268:DNA-Binding Proteins; C000607891:DNL4 protein, S cerevisiae; C000607893:LIG4 protein, human; D010455:Peptides; C101467:XRCC4 protein, human; D004254:DNA Nucleotidyltransferases; D045567:VDJ Recombinases; D011088:DNA Ligases; D000072481:DNA Ligase ATP